GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OptiBiotix Health PLC (LSE:OPTI) » Definitions » Net Current Asset Value

OptiBiotix Health (LSE:OPTI) Net Current Asset Value : £0.01 (As of Jun. 2023)


View and export this data going back to 2011. Start your Free Trial

What is OptiBiotix Health Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

OptiBiotix Health's net current asset value per share for the quarter that ended in Jun. 2023 was £0.01.

The historical rank and industry rank for OptiBiotix Health's Net Current Asset Value or its related term are showing as below:

LSE:OPTI' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 7   Med: 22.34   Max: 93.5
Current: 17.75

During the past 12 years, the highest Price-to-Net-Current-Asset-Value Ratio of OptiBiotix Health was 93.50. The lowest was 7.00. And the median was 22.34.

LSE:OPTI's Price-to-Net-Current-Asset-Value is ranked worse than
89.24% of 1032 companies
in the Biotechnology industry
Industry Median: 3.905 vs LSE:OPTI: 17.75

OptiBiotix Health Net Current Asset Value Historical Data

The historical data trend for OptiBiotix Health's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OptiBiotix Health Net Current Asset Value Chart

OptiBiotix Health Annual Data
Trend Jul10 Jul12 Nov14 Nov15 Nov16 Nov17 Nov18 Dec20 Dec21 Dec22
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.01 0.01 - 0.02 0.01

OptiBiotix Health Semi-Annual Data
Jul12 Jan13 May14 Nov14 May15 Nov15 May16 Nov16 May17 Nov17 May18 Nov18 May19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.02 0.02 0.01 0.01

Competitive Comparison of OptiBiotix Health's Net Current Asset Value

For the Biotechnology subindustry, OptiBiotix Health's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OptiBiotix Health's Price-to-Net-Current-Asset-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OptiBiotix Health's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where OptiBiotix Health's Price-to-Net-Current-Asset-Value falls into.



OptiBiotix Health Net Current Asset Value Calculation

OptiBiotix Health's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2022 is calculated as

Net Current Asset Value Per Share(A: Dec. 2022 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(1.857-0.643-0-0)/91.1907
=0.01

OptiBiotix Health's Net Current Asset Value (NCAV) per share for the quarter that ended in Jun. 2023 is calculated as

Net Current Asset Value Per Share(Q: Jun. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(1.844-0.862-0-0)/91.1907
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OptiBiotix Health  (LSE:OPTI) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


OptiBiotix Health Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of OptiBiotix Health's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


OptiBiotix Health (LSE:OPTI) Business Description

Traded in Other Exchanges
Address
Innovation Centre, Innovation Way, Heslington, York, GBR, YO10 5DG
OptiBiotix Health PLC is engaged in the field of healthcare. As a life science company, its prime focus lies in researching the area of biotechnology. Its activities include the identification of microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology, deriving potential health benefits. The company derives majority of the revenue from the sale of Functional Fibres. The company markets its products in the United Kingdom under trademark names such as OptiBiotix, SweetBiotix, and SkinBioTherapeutics.